Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Semler Scientific, Inc. SMLR NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
88/100
6/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$40.00
+96.8%

Semler Scientific, Inc. (SMLR) is a Medical - Devices company in the Healthcare sector, currently trading at $20.33. It has a SharesGrow Score of 88/100, indicating a strong investment profile with 6 out of 7 criteria passed.

Analyst consensus target is SMLR = $40 (+96.8% upside).

Financials: revenue is $56M, +3.2%/yr average growth. Net income is $41M, growing at +41.9%/yr. Net profit margin is 72.7% (strong). Gross margin is 91.5% (+3 pp trend).

Balance sheet: total debt is $70,000 against $231M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 3.59 (strong liquidity). Debt-to-assets is 0%. Total assets: $240M.

Analyst outlook: 6 / 7 analysts rate SMLR as buy (86%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 73/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 50/100 (Partial), Future 94/100 (Pass), Income 100/100 (Pass).

$40.00
▲ 96.75% Upside
Average Price Target
The 12-month price target for Semler Scientific, Inc. is $40.00.

SMLR SharesGrow Score Overview

88/100
SharesGrow Score
Strong investment profile
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 73/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 94/100
Analyst outlook — as buy
INCOME 100/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SMLR

✓
VALUE Pass
100/100
SMLR trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $40, implying +96.8% from the current price $20. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
GROWTH Pass
73/100
SMLR: +3.2%/yr revenue is, +41.9%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
SMLR: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
100/100
Balance sheet SMLR: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 3.59 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
50/100
SMLR: Gross margin is 91.5% (+3 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
94/100
Analyst outlook: 6 / 7 analysts rate SMLR as buy (86%). Analyst consensus target is $40 (+96.8% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✓
INCOME Pass
100/100
SMLR: Net profit margin is 72.7%. strong (≥30%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range14.885-65.98
Volume1.62M
Avg Volume (30D)647.86K
Market Cap$310.75M
Beta (1Y)1.32
Share Statistics
EPS (TTM)5.66
Shares Outstanding$7.23M
IPO Date2014-02-21
Employees79
CEODouglas Murphy-Chutorian
Financial Highlights & Ratios
Revenue (TTM)$56.29M
Gross Profit$51.54M
EBITDA$21.51M
Net Income$40.9M
Operating Income$20.93M
Total Cash$14.92M
Total Debt$70K
Net Debt$-8.75M
Total Assets$239.83M
Price / Earnings (P/E)3.6
Price / Sales (P/S)5.52
Analyst Forecast
1Y Price Target$40.00
Target High$40.00
Target Low$40.00
Upside+96.8%
Rating ConsensusBuy
Analysts Covering7
Buy 86% Hold 14% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS81684M1045

Price Chart

Track all markets on TradingView
SMLR
Semler Scientific, Inc. ↗  ·  NASDAQ Capital Marke
Healthcare • Medical - Devices
14.89 52WK RANGE 65.98

People Also View

TMDX
TMDX
TransMedics Group, Inc.
$116.11
+0.37%
 LIVN
LIVN
LivaNova PLC
$65.14
+0.23%
 AORT
AORT
Artivion, Inc.
$37.47
-1.26%
 HSKA
HSKA
Heska Corporation
$119.99
+0.00%
 SRDX
SRDX
Surmodics, Inc.
$42.98
+0.35%
 NPCE
NPCE
NeuroPace, Inc.
$15.61
+1.69%
 OFIX
OFIX
Orthofix Medical Inc.
$12.87
+1.18%
 KIDS
KIDS
OrthoPediatrics Corp.
$17.85
-0.06%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message